Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy.

Rose J, Wertheim BC, Guerrero MA.

Am J Surg. 2012 Dec;204(6):881-6; discussion 886-7. doi: 10.1016/j.amjsurg.2012.07.030. Epub 2012 Sep 29.

PMID:
23026382
2.

Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.

Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, Strong LC, Hammond S, Neglia JP, Meadows AT, Robison L, Diller L.

J Natl Cancer Inst. 2007 Feb 21;99(4):300-8.

PMID:
17312307
3.

Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.

Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ.

J Natl Cancer Inst. 2009 Jul 1;101(13):946-58. doi: 10.1093/jnci/djp148. Epub 2009 Jun 17.

4.

Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma.

Huang J, Walker R, Groome PG, Shelley W, Mackillop WJ.

Cancer. 2001 Sep 15;92(6):1411-8.

PMID:
11745217
5.

Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.

Acharya S, Sarafoglou K, LaQuaglia M, Lindsley S, Gerald W, Wollner N, Tan C, Sklar C.

Cancer. 2003 May 15;97(10):2397-403.

6.

Second neoplasms after megavoltage radiation for pediatric tumors.

Gold DG, Neglia JP, Dusenbery KE.

Cancer. 2003 May 15;97(10):2588-96.

7.

Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy.

Haddy N, Andriamboavonjy T, Paoletti C, Dondon MG, Mousannif A, Shamsaldin A, Doyon F, Labbé M, Robert C, Avril MF, Fragu P, Eschwege F, Chavaudra J, Schvartz C, Lefkopoulos D, Schlumberger M, Diallo I, de Vathaire F.

Radiother Oncol. 2009 Nov;93(2):377-82. doi: 10.1016/j.radonc.2009.05.011. Epub 2009 Jun 8.

PMID:
19515442
8.

Pediatric solid tumors and second malignancies: characteristics and survival outcomes.

Vasudevan V, Cheung MC, Yang R, Zhuge Y, Fischer AC, Koniaris LG, Sola JE.

J Surg Res. 2010 May 15;160(2):184-9. doi: 10.1016/j.jss.2009.05.030. Epub 2009 Jun 21.

PMID:
19765728
9.

Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.

Wright JD, St Clair CM, Deutsch I, Burke WM, Gorrochurn P, Sun X, Herzog TJ.

Cancer. 2010 May 15;116(10):2486-92. doi: 10.1002/cncr.25067.

10.

The risk of multiple primary breast and thyroid carcinomas.

Adjadj E, Rubino C, Shamsaldim A, Lê MG, Schlumberger M, de Vathaire F.

Cancer. 2003 Sep 15;98(6):1309-17.

11.

Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.

Gao X, Fisher SG, Emami B.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1038-45.

PMID:
12829139
12.

Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.

Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF.

Cancer Lett. 2006 Jul 8;238(1):42-52. Epub 2005 Jul 21.

PMID:
16039041
13.

Childhood cancer among Alaska Natives.

Lanier AP, Holck P, Ehrsam Day G, Key C.

Pediatrics. 2003 Nov;112(5):e396.

PMID:
14595083
14.

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ.

Blood. 1996 May 1;87(9):3625-32.

15.

Thyroid adenomas after solid cancer in childhood.

Haddy N, El-Fayech C, Guibout C, Adjadj E, Thomas-Teinturier C, Oberlin O, Veres C, Pacquement H, Jackson A, Munzer M, N'Guyen TD, Bondiau PY, Berchery D, Laprie A, Bridier A, Lefkopoulos D, Schlumberger M, Rubino C, Diallo I, de Vathaire F.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e209-15. doi: 10.1016/j.ijrobp.2012.03.044. Epub 2012 Jun 5.

PMID:
22672756
16.

Breast cancer after treatment of Hodgkin's disease.

Hancock SL, Tucker MA, Hoppe RT.

J Natl Cancer Inst. 1993 Jan 6;85(1):25-31.

PMID:
8416252
17.

Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.

Zacharatou Jarlskog C, Paganetti H.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):228-35. doi: 10.1016/j.ijrobp.2008.04.069. Epub 2008 Jun 18.

PMID:
18571337
18.
19.

Second tumors in pediatric patients treated with radiotherapy to the central nervous system.

Galloway TJ, Indelicato DJ, Amdur RJ, Swanson EL, Smith AA, Marcus RB Jr.

Am J Clin Oncol. 2012 Jun;35(3):279-83. doi: 10.1097/COC.0b013e318210f533.

PMID:
21383606
20.

Incidence of second cancers in patients treated for Hodgkin's disease.

Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P, et al.

J Natl Cancer Inst. 1995 May 17;87(10):732-41.

PMID:
7563150

Supplemental Content

Support Center